Table 1 Demographic, clinical and immunological characteristics of the patients with SSc (n = 134, 100%)
Variable | Result |
|---|---|
Age at SSc onset (years) | 38.5 (± 15.7) |
Age at NVC (years) | 54.7 (± 14.4) |
Cutaneous subsets, dcSSc/lcSSc/ssSSc | 28 (20.9)/88 (65.7)/18 (13.4) |
Time elapsed from first symptom to NVC (years) | 16.0 (± 12.6) |
Time elapsed from first non-RP symptom to NVC (years) | 10.9 (± 9.9) |
2013 ACR/EULAR SSc classification criteria fulfilment | 121 (90.2) |
ACA/ATA/anti-RNA pol III/anti-PM/Scl | 49 (36.6)/31 (23.1)/14 (10.4)/11 (8.2) |
Raynaud’s phenomenon | 132 (98.5) |
Telangiectasias | 97 (72.4) |
Digital ulcers | 62 (46.3) |
Calcinosis | 29 (21.6) |
Scleroderma renal crisis | 2 (1.5) |
Interstitial lung disease | 58 (43.3) |
Pulmonary arterial hypertension | 11 (8.2) |
Cardiac involvement | 103 (76.9) |
Musculoskeletal disease | 40 (29.9) |
Gastrointestinal involvement | 110 (82.1) |
Overlap features | 19 (14.1) |